Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Mississippi guideMississippi Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Mississippi
  4. ›Healthcare and Medical Services
  5. ›Model Care Coordinator/Grant Manager – Cell & Gene Therapy…

Mississippi Division of Medicaid·Mississippi

Model Care Coordinator/Grant Manager – Cell & Gene Therapy Access Model

Closes 2/5/2026$90k – $110k
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Mississippi Division of Medicaid is soliciting applications for a Model Care Coordinator/Grant Manager to implement the Centers for Medicare and Medicaid Services (CMS) Cell and Gene Therapy Access Model. The successful applicant will support members receiving cell and gene therapies for sickle cell disease, act as a liaison between the Mississippi Division of Medicaid, model members, caregivers, providers, and community-based organizations, and perform various responsibilities such as guiding model members, developing care plans, and coordinating resources. The initial contract term will be approximately five years, commencing on April 1, 2026, and concluding on December 31, 2030. The rate of pay will be $50.48 an hour, not to exceed 1840 hours annually. Key responsibilities include: • Acting as the primary liaison for the CGT Access Model • Guiding model members through the full treatment journey • Performing telephonic, digital, home, and/or other site visits • Developing and reviewing ongoing, individualized care plans • Conducting barriers to access screenings • Connecting members to supportive resources • Coordinating between the member and/or family/caregivers, community resources, and the care provider team • Collecting, documenting, and maintaining member information, care management activities, and model activities • Providing and supporting educational training for patients, communities, and providers • Assisting with oversight of the Model Community Outreach Specialists • Developing and maintaining project documentation, standard operating procedures, workflows, and reports related to the model • Contributing to internal and external communications related to the model • Identifying and implementing continuous improvement opportunities • Assisting the Mississippi Division of Medicaid with miscellaneous tasks related to the Cell and Gene Therapy Access Model

Attached files

Contact

Sharon Clark(Procurement Officer)

[email protected]

Key dates

Opened
1/16/2026
Questions due
1/26/2026
Closes
2/5/2026
Duration
5 years

Last updated

Details

Industry
Healthcare and Medical Services
NAICS
621110
Solicitation №
1628-26-R-RFIN-00005-V01

Budget estimate

$90,000 – $110,000

The maximum annual compensation payable for the contract shall be $109,032.76, which includes the hourly rate of $50.48, not to exceed 1840 hours annually, and additional payments for fringe rate and travel. This amount is provided in the document, so it can be used as a basis for the budget estimation. The budget range can be estimated as $90,000 to $110,000 per year, considering the hourly rate and the maximum annual compensation. Factors that may influence the likely payment range include the number of hours worked, the fringe rate, and travel expenses.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 69%

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

68% match

Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)

Closes 7/12/2027Opened 7/11/2024

U.S. National Institutes of Health·United States of America

68% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

68% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

68% match

Promoting Cancer Surveillance Workforce, Education, and Data Use

Closes 4/6/2027Opened 9/28/2026

U.S. National Institutes of Health·United States of America

67% match

Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 4/8/2026

U.S. National Institutes of Health·United States of America

67% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

67% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

67% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

67% match

Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)

Closes 1/9/2029Opened 6/9/2025

U.S. National Institutes of Health·United States of America

67% match

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Closes 1/11/2027Opened 9/17/2025

U.S. National Institutes of Health·United States of America

67% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

67% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

67% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

67% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

66% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

66% match

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

66% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

66% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

66% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

66% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

66% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026